Detalhe da pesquisa
1.
MenACWY-CRM conjugate vaccine booster dose given 4-6â¯years after priming: Results from a phase IIIb, multicenter, open label study in adolescents and adults.
Vaccine
; 37(42): 6171-6179, 2019 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31495595
2.
A comparative evaluation of two investigational meningococcal ABCWY vaccine formulations: Results of a phase 2 randomized, controlled trial.
Vaccine
; 33(21): 2500-10, 2015 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25795256